Loading...

ASKA Pharmaceutical Holdings Co.,Ltd.

4886.TJPX
Healthcare
Drug Manufacturers - Specialty & Generic
¥2328.00
¥-135.00(-5.48%)

ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) Company Profile & Overview

Explore ASKA Pharmaceutical Holdings Co.,Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) Company Profile & Overview

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOTakashi Yamaguchi

Contact Information

81 3 5484 8845
5-1, Shibaura 2-Chome, Tokyo, 108-8532

Company Facts

762 Employees
IPO DateApr 1, 2021
CountryJP
Actively Trading

Frequently Asked Questions

;